A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands
Public ClinicalTrials.gov record NCT00657774. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel Group, 6-Week Study to Evaluate the Effect of Multiple Doses of FlutiForm™ 250/10 Microgram HFA pMDI Twice Daily, FlutiForm™ 100/10 Microgram HFA pMDI Twice Daily, Prednisone and Placebo on the Hypothalmic-Pituitary-Adrenal Axis in Adult Subjects With Mild to Moderate Asthma.
Study identification
- NCT ID
- NCT00657774
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- SkyePharma AG
- Industry
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Interventions
- FlutiForm 250/10 ug Drug
- FlutiForm 100/10 ug Drug
- Oral Prednisone 10mg Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2008
- Primary completion
- Aug 31, 2008
- Completion
- Aug 31, 2008
- Last update posted
- Nov 30, 2008
2008
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational site | Phoenix | Arizona | 85006 | — |
| Investigational site | Anaheim | California | 92801 | — |
| Investigational site | Long Beach | California | 90806 | — |
| Investigational site | San Diego | California | 92120 | — |
| Investigational site | Centennial | Colorado | 80112 | — |
| Investigational site | Colorado Springs | Colorado | 80907 | — |
| Investigational site | Denver | Colorado | 80206 | — |
| Investigational site | Lakewood | Colorado | 80401 | — |
| Investigational site | DeLand | Florida | 32720 | — |
| Investigational Site | Pasadena | Maryland | 21122 | — |
| Investigational site | North Dartmouth | Massachusetts | 02747 | — |
| Investigational site | Omaha | Nebraska | 68154 | — |
| Investigational site | Skillman | New Jersey | 08558 | — |
| Investigational Site | Lake Oswego | Oregon | 97035 | — |
| Investigational site | Portland | Oregon | 97213 | — |
| Investigational site | Spartanburg | South Carolina | 29303 | — |
| Investigational site | El Paso | Texas | 79902 | — |
| Investigational site | New Braunfels | Texas | 78130 | — |
| Investigational site | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00657774, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 30, 2008 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00657774 live on ClinicalTrials.gov.